NCT00612326 Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging Status COMPLETED Phase N/A
NCT00609843 Pilot Studie of Lipiodol Demarcation of the Tumour in Bladder Cancer Status COMPLETED Phase NA
NCT00598806 Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612) Status COMPLETED Phase PHASE3
NCT00587964 Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases Status COMPLETED Phase PHASE2
NCT00585689 Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer Status COMPLETED Phase PHASE2
NCT00583349 Intravesicular Abraxane for Treatment-Refractory Bladder Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00582387 Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer Status COMPLETED Phase N/A
NCT00579514 Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients Status ACTIVE_NOT_RECRUITING Phase NA
NCT00578526 SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial Status COMPLETED Phase PHASE2
NCT00578006 Internet-based System for Cancer Patients to Self-report Toxicity Status COMPLETED Phase NA
NCT00567684 Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors Status ACTIVE_NOT_RECRUITING Phase NA
NCT00565227 Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies. Status TERMINATED Phase PHASE1
NCT00556621 Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00553566 Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer Status UNKNOWN Phase N/A
NCT00553345 Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer Status UNKNOWN Phase PHASE3
NCT00553124 Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer Status UNKNOWN Phase PHASE3
NCT00544609 Sorafenib and Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative Intent Status COMPLETED Phase PHASE1